Annual Accounts Payable
$1.52 M
-$30.00 K-1.93%
December 31, 2023
Summary
- As of February 8, 2025, TBPH annual accounts payable is $1.52 million, with the most recent change of -$30.00 thousand (-1.93%) on December 31, 2023.
- During the last 3 years, TBPH annual accounts payable has fallen by -$5.25 million (-77.51%).
- TBPH annual accounts payable is now -91.90% below its all-time high of $18.80 million, reached on December 31, 2015.
Performance
TBPH Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.45 M
-$220.00 K-13.14%
September 30, 2024
Summary
- As of February 8, 2025, TBPH quarterly accounts payable is $1.45 million, with the most recent change of -$220.00 thousand (-13.14%) on September 30, 2024.
- Over the past year, TBPH quarterly accounts payable has dropped by -$914.00 thousand (-38.60%).
- TBPH quarterly accounts payable is now -92.27% below its all-time high of $18.80 million, reached on December 31, 2015.
Performance
TBPH Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TBPH Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.9% | -38.6% |
| 3 y3 years | -77.5% | -83.7% |
| 5 y5 years | -83.1% | -78.5% |
TBPH Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.8% | at low | -72.8% | at low |
| 5 y | 5-year | -77.5% | at low | -86.4% | at low |
| alltime | all time | -91.9% | at low | -92.3% | at low |
Theravance Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.45 M(-13.1%) |
| Jun 2024 | - | $1.67 M(-0.7%) |
| Mar 2024 | - | $1.69 M(+10.6%) |
| Dec 2023 | $1.52 M(-1.9%) | $1.52 M(-35.6%) |
| Sep 2023 | - | $2.37 M(+50.9%) |
| Jun 2023 | - | $1.57 M(-41.1%) |
| Mar 2023 | - | $2.66 M(+71.4%) |
| Dec 2022 | $1.55 M(-49.8%) | $1.55 M(-70.9%) |
| Sep 2022 | - | $5.34 M(+73.6%) |
| Jun 2022 | - | $3.07 M(+103.6%) |
| Mar 2022 | - | $1.51 M(-51.3%) |
| Dec 2021 | $3.10 M(-54.3%) | $3.10 M(-65.2%) |
| Sep 2021 | - | $8.90 M(-16.8%) |
| Jun 2021 | - | $10.70 M(+56.6%) |
| Mar 2021 | - | $6.83 M(+0.9%) |
| Dec 2020 | $6.78 M(+42.4%) | $6.78 M(+5.2%) |
| Sep 2020 | - | $6.44 M(-36.0%) |
| Jun 2020 | - | $10.06 M(+51.5%) |
| Mar 2020 | - | $6.64 M(+39.7%) |
| Dec 2019 | $4.76 M | $4.76 M(-45.4%) |
| Sep 2019 | - | $8.71 M(+148.9%) |
| Jun 2019 | - | $3.50 M(-37.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $5.60 M(-38.0%) |
| Dec 2018 | $9.03 M(+52.4%) | $9.03 M(+141.1%) |
| Sep 2018 | - | $3.75 M(+2.8%) |
| Jun 2018 | - | $3.64 M(-28.3%) |
| Mar 2018 | - | $5.08 M(-14.2%) |
| Dec 2017 | $5.92 M(+241.8%) | $5.92 M(+5.4%) |
| Sep 2017 | - | $5.62 M(-12.2%) |
| Jun 2017 | - | $6.41 M(+76.7%) |
| Mar 2017 | - | $3.63 M(+109.2%) |
| Dec 2016 | $1.73 M(-90.8%) | $1.73 M(-67.6%) |
| Sep 2016 | - | $5.35 M(-27.8%) |
| Jun 2016 | - | $7.41 M(-18.5%) |
| Mar 2016 | - | $9.09 M(-51.6%) |
| Dec 2015 | $18.80 M(+89.5%) | $18.80 M(+215.3%) |
| Sep 2015 | - | $5.96 M(-5.9%) |
| Jun 2015 | - | $6.33 M(+57.5%) |
| Mar 2015 | - | $4.02 M(-59.5%) |
| Dec 2014 | $9.92 M(+43.0%) | $9.92 M(+87.8%) |
| Sep 2014 | - | $5.28 M(-44.4%) |
| Jun 2014 | - | $9.50 M(+90.6%) |
| Mar 2014 | - | $4.98 M(-28.2%) |
| Dec 2013 | $6.94 M | $6.94 M |
FAQ
- What is Theravance Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Theravance Biopharma?
- What is Theravance Biopharma annual accounts payable year-on-year change?
- What is Theravance Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Theravance Biopharma?
- What is Theravance Biopharma quarterly accounts payable year-on-year change?
What is Theravance Biopharma annual accounts payable?
The current annual accounts payable of TBPH is $1.52 M
What is the all time high annual accounts payable for Theravance Biopharma?
Theravance Biopharma all-time high annual accounts payable is $18.80 M
What is Theravance Biopharma annual accounts payable year-on-year change?
Over the past year, TBPH annual accounts payable has changed by -$30.00 K (-1.93%)
What is Theravance Biopharma quarterly accounts payable?
The current quarterly accounts payable of TBPH is $1.45 M
What is the all time high quarterly accounts payable for Theravance Biopharma?
Theravance Biopharma all-time high quarterly accounts payable is $18.80 M
What is Theravance Biopharma quarterly accounts payable year-on-year change?
Over the past year, TBPH quarterly accounts payable has changed by -$914.00 K (-38.60%)